Access options
Subscribe to Journal
Get full journal access for 1 year
$499.00
only $41.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
from$8.99
All prices are NET prices.
References
- 1.
Mohty M, Malard F, Abecassis M, Aerts E, Alaskar AS, Aljurf M, et al. Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation. Bone Marrow Transpl. 2016;51:906–12. https://doi.org/10.1038/bmt.2016.130.
- 2.
Corbacioglu S, Carreras E, Ansari M, Balduzzi A, Cesaro S, Dalle JH, et al. Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation. Bone Marrow Transpl. 2018;53:138–45. https://doi.org/10.1038/bmt.2017.161. e-pub ahead of print 02/08/2017.
- 3.
Corbacioglu S, Kernan NA, Pagliuca A, Ryan RJ, Tappe W, Richardson PG. Incidence of anicteric veno-occlusive disease/sinusoidal obstruction syndrome and outcomes with defibrotide following hematopoietic cell transplantation in adult and pediatric patients. Biol Blood Marrow Transpl. 2020. https://doi.org/10.1016/j.bbmt.2020.03.011. e-pub ahead of print 23/03/2020.
- 4.
McDonald GB, Hinds MS, Fisher LD, Schoch HG, Wolford JL, Banaji M, et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med. 1993;118:255–67.
- 5.
Corbacioglu S, Greil J, Peters C, Wulffraat N, Laws HJ, Dilloo D, et al. Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention. Bone Marrow Transpl. 2004;33:189–95.
- 6.
Richardson PG, Smith AR, Kernan NA, Antin JH, Lehmann L, Ryan RJ, et al. Pooled analysis of day +100 survival for defibrotide-treated patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome (vod/sos) and ventilator or dialysis dependence following hematopoietic stem cell transplantation (HSCT). Blood. 2017;130:1946. https://doi.org/10.1182/blood.V130.Suppl_1.1946.1946.
- 7.
Grupp SA, Smith AR, Triplett BM, Kernan NA, Antin JH, Lehmann L, et al. Timing of initiation of defibrotide post-diagnosis of hepatic veno-occlusive disease/sinusoidal obstruction syndrome post-hematopoietic stem cell transplantation: exploratory age-group analysis from an expanded access study. Blood. 2016;128:66. https://doi.org/10.1182/blood.V128.22.66.66.
- 8.
Coppell JA, Richardson PG, Soiffer R, Martin PL, Kernan NA, Chen A, et al. Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. Biol Blood Marrow Transpl. 2010;16:157–68. https://doi.org/10.1016/j.bbmt.2009.08.024.
- 9.
Yakushijin K, Atsuta Y, Doki N, Yokota A, Kanamori H, Miyamoto T, et al. Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: Incidence, risk factors and outcomes. Bone Marrow Transpl. 2016;51:403–9. https://doi.org/10.1038/bmt.2015.283.
- 10.
Embaby MM, Rangarajan HG, Abu-Arja R, Auletta JJ, Stanek J, Pai V, et al. Refractory thrombocytopenia is a valid early diagnostic criteria for hepatic veno-occlusive disease in children. Biol Blood Marrow Transpl. 2020;26:546–52. https://doi.org/10.1016/j.bbmt.2019.11.012. e-pub ahead of print 23/11/2019.
- 11.
Szmit Z, Gorczynska E, Król A, Ussowicz M, Mielcarek-Siedziuk M, Olejnik I, et al. Introduction of new pediatric EBMT criteria for VOD diagnosis: is it time-saving or money-wasting?: Prospective evaluation of pediatric EBMT criteria for VOD. Bone Marrow Transpl. 2020. https://doi.org/10.1038/s41409-020-0918-1. e-pub ahead of print 14/05/2020.
- 12.
Ragoonanan D, Khazal SJ, Wang J, Payne A, Kohorst M, Harden A, et al. Improved detection of sinusoidal obstructive syndrome using pediatric-AYA diagnostic criteria and severity grading. Bone Marrow Transpl. 2020. https://doi.org/10.1038/s41409-020-00998-w. e-pub ahead of print 16/07/2020.
Author information
Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author declares that he has no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Corbacioglu, S. The coming of age of the pediatric EBMT criteria. Bone Marrow Transplant (2020). https://doi.org/10.1038/s41409-020-01141-5
Received:
Revised:
Accepted:
Published: